Overcoming obstacles in pharmacogenomic strategies for antiplatelet drugs: are we RAPID enough?
Derek Y F
DY
So
Jason D
JD
Roberts
D001189:Aryl Hydrocarbon Hydroxylases / Q000235:genetics*; D054316:Biomarkers, Pharmacological; D002986:Clinical Trials as Topic; D065731:Cytochrome P-450 CYP2C19; D055106:Genome-Wide Association Study; D006801:Humans; D010597:Pharmacogenetics; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage / Q000378:metabolism; D013927:Thrombosis / Q000235:genetics
D054316:Biomarkers, Pharmacological; D010975:Platelet Aggregation Inhibitors; D001189:Aryl Hydrocarbon Hydroxylases; C045793:CYP2C19 protein, human; D065731:Cytochrome P-450 CYP2C19